CORE Biomedicine Secures $21 Million Series A Venture Financing and Receives AMED Grant Award to Advance Novel Cancer Therapeutics

The venture financing and AMED grant funding position CORE to accelerate development of novel lineage-based oncology therapies for patients around the world. BOSTON and TOKYO and SUZHOU, China, July 28, 2026 /PRNewswire/ -- CORE Biomedicine, a biotechnology company pioneering...